Snowball logo
logo
ACRS

Aclaris Therapeutics Inc

ACRS NASDAQ
$3.51-$0.09  (2.5%)

Frequently asked questions

What sector does Aclaris Therapeutics Inc (ACRS) operate in?

Aclaris Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Aclaris Therapeutics Inc (ACRS) current stock price?

As of the latest data, Aclaris Therapeutics Inc stock price is $3.51, with a previous close of $3.60. Aclaris Therapeutics Inc lost -$0.09 in the last trading session, representing a -2.5% loss.

What is Aclaris Therapeutics Inc (ACRS) current market capitalization?

Aclaris Therapeutics Inc market cap is approximately 380.29 million.

What is Aclaris Therapeutics Inc (ACRS) Earnings Per Share (EPS)?

The trailing EPS is -$1.58, and the forward EPS is -$0.80.

What is Aclaris Therapeutics Inc (ACRS) EBITDA?

Aclaris Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.69 million.

Does Aclaris Therapeutics Inc (ACRS) pay dividends?

No. Aclaris Therapeutics Inc does not pay a dividend.

How did Aclaris Therapeutics Inc (ACRS) perform in its most recent earnings report?

In the last report (December 31, 2025), Aclaris Therapeutics Inc posted an EPS surprise of -6.67% and a revenue surprise of -83.8%.

When is Aclaris Therapeutics Inc (ACRS) next earnings report?

Aclaris Therapeutics Inc is expected to release its next earnings report on March 31, 2026.

What is Aclaris Therapeutics Inc (ACRS) beta (volatility) score?

Aclaris Therapeutics Inc has a beta of 0.868, meaning its volatility is roughly in line with the market.